CAS NO 139755-83-2
Sildenafil citrate, sold as Viagra, Revatio and under various other trade names, is a drug used to treat erectile dysfunction and pulmonary arterial hypertension (PAH). It was originally developed by British scientists and then brought to market by the US-based pharmaceutical company Pfizer.It acts by inhibiting cGMP-specific phosphodiesterase type 5 (PDE5), an enzyme that promotes degradation of cGMP, which regulates blood flow in the penis. Since becoming available in 1998, sildenafil has been the prime treatment for erectile dysfunction; its primary competitors on the market are tadalafil (Cialis) and vardenafil (Levitra)
symptoms in patients with pulmonary arterial hypertension (PAH).
via phosphodiesterase type 5 (PDE5). PDE5 is found in particularly high
concentrations in the corpus cavernosum, erectile tissue of the penis.
maintenance of an erection. The vasodilatory effects of sildenafil also help reduce
symptoms of PAH.
Sildenafil citrate, sold as Viagra, Revatio and under various other trade names,
is adrug used to treat erectile dysfunction and pulmonary arterial
It was originally developed by British scientists and then brought to market by the
US-basedpharmaceutical company Pfizer.
through affymetrix microarrays.
chromatographic techniques, spectrophotometric methods, adsorptive
improved errections in almost 90% of patients.
The chemical name of sildenafil is 5-[2-ethoxy-5-(4-methylpiperazin-1-ylsulfonyl)phenyl]-1- methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one and its formula is C22H30N6O4S. The melting point of sildenafil is 189-190oC. Its solubility is 3.5 mg/mL in water.
|The 1H NMR data of sildenafil is given below. The abbreviations used are s for singlet, d for doublet, t for triplet and q for quartet. The chemical shifts are given in ppm (parts per million) and are followed by the number of Hydrogens the peaks account for:|
Viagra aims at inhibiting the enzyme phosphodiesterase PDE5. It must therefore have a structure that is similar in some places to the substrate. However, there are many other constraints as there are several different types of PDE enzymes which are found in different parts of the body. Of the 7 types of PDE, three selectively hydrolyse cGMP relative to cAMP. PDE5 itself can be found in several parts of the body : the lungs, platelets and various forms of smooth muscle. Selectivety was a very important factor in the research for an inhibitor of PDE5.
The research on a molecule to inhibit PDE type 5 started with the molecule Zaprinast (1) which is shown on the right. The research established that derivatives of pyrazolo[4,3-d]pyrimidin-7-one (2) gave more potent cGMP PDE5 inhibition. The studies carried out compared many molecules by changing the substituents on them and comparing the inhibitory data of these molecules. To establish the selectivity of the compound, the compounds were also screened against the other widespread cGMP enzymes, PDE1 which was isolated from rat liver and PDE3 which was isolated from rat platelet. Further studies showed that sildenafil was the best PDE5 inhibitor.
The different functional groups on the molecule were established by comparing the affinities of the molecules to the different PDE enzymes and establishing the selectivity of each compound made. Of course, high selectivity for PDE type 5 was looked for.
Viagra mimics the guanosine base of cGMP and the extension of 3-substituent fills a space in the enzyme active site occupied by ribose. Substituents on the 5'-position of the phenyl ring reproduce the role of the phosphate bonding.
To improve the solubility of the drug, polar substituents were added which gave compounds with a lower lipophilicity. This was found to also increase the enzyme affinity.
Sidenafil gave an excellent combination of enzyme inhibitory potency, selectivity, solubility and in vivo characteristics.
It is interesting to compare the structure of sidenafil with that of cGMP (cyclic guanosine monophosphate), which is the molecule that usually interacts with PDE5. The drug that was being developed by the researchers had to have some similarity so that it could bind to the active site of the enzyme, PDE5. The 2 dimensional structure of cGMP is given above the 3 dimensional picture, however the latter can be used to view the molecule in 2D as well, with any orientation of the molecule. The first figure also shows that cGMP and pyrazolo[4,3-d]pyrimidin-7-one, which is one of the parent molecules of sildenafil, have a similar size, shape and dipole moment. These were characteristics that were looked for in a molecule that would inhibit PDE5. The following molecule is cGMP :
Sildenafil citrate is a white to off-white crystalline powder with a solubility of 3.5 mg/mL in water and a molecular weight of 666.7. Sildenafil citrate has most recently been utilized as the basis for an oral therapy for erectile dysfunction and has been marketed by Pfizer Labs under the trademark Viagra®. Publications relating to benign visual side-effects (e.g., blue-shift in vision, light-sensitivity, and blurring noted to occur in some patients) of sildenafil prompted the FDA to insist on product insert warnings.
- Methylation of 3-propylpyrazole-5-carboxylic acid ethyl ester with hot dimethyl sulfate
- Hydrolysis with aqueous NaOH to free acid
- Nitration with oleum/fuming nitric acid
- Carboxamide formation with refluxing thionyl chloride/NH4OH
- Reduction of nitro group to amino
- Acylation with 2-ethoxybenzoyl chloride
- Sulfonation to the chlorosulfonyl derivative
- Condensation with 1-methylpiperazine.
Patent issues and expirations
- Boolell M, Allen MJ, Ballard SA, Gepi-Attee S, Muirhead GJ, Naylor AM, Osterloh IH, Gingell C (June 1996). "Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction". Int. J. Impot. Res. 8 (2): 47–52.PMID 8858389.
- Vardi M, Nini A (2007). "Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus". In Vardi, Moshe. Cochrane Database Syst Rev (1): CD002187.doi:10.1002/14651858.CD002187.pub3. PMID 17253475.
- Nurnberg HG, Hensley PL, Gelenberg AJ, Fava M, Lauriello J, Paine S (January 2003)."Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial". JAMA 289 (1): 56–64. doi:10.1001/jama.289.1.56. PMID 12503977.
- Nurnberg HG, Hensley PL, Lauriello J, Parker LM, Keith SJ (August 1999). "Sildenafil for women patients with antidepressant-induced sexual dysfunction". Psychiatr Serv 50 (8): 1076–8. PMID 10445658.
- Nurnberg HG, Hensley PL, Heiman JR, Croft HA, Debattista C, Paine S (2008). "Sildenafil Treatment of Women With Antidepressant-Associated Sexual Dysfunction". JAMA 300 (4): 395–404. doi:10.1001/jama.300.4.395. PMID 18647982.
- "FDA Approves Pfizer's Revatio as Treatment for Pulmonary Arterial Hypertension" (Press release). Pfizer. June 6, 2005. Archived from the original on August 28, 2005.
- Richalet JP, Gratadour P, Robach P, et al. (2005). "Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension". Am. J. Respir. Crit. Care Med. 171 (3): 275–81.doi:10.1164/rccm.200406-804OC. PMID 15516532.
- Perimenis P (2005). "Sildenafil for the treatment of altitude-induced hypoxaemia". Expert Opin Pharmacother 6 (5): 835–7. doi:10.1517/146565184.108.40.2065. PMID 15934909.
- Fagenholz PJ, Gutman JA, Murray AF, Harris NS (2007). "Treatment of high altitude pulmonary edema at 4240 m in Nepal". High Alt. Med. Biol. 8 (2): 139–46.doi:10.1089/ham.2007.3055. PMID 17584008.
- "Pill Identifier". Drugs.com. Retrieved 2009-02-10. "This site is intended for viewing by the USA audience only. If you are in another country, local laws may not permit access to the medical information contained in this site."
- "Viagra Prescribing Information" (PDF). Pfizer. October 2007. Archived from the original on 14 November 2012. Retrieved 14 November 2012.
- "Viagra and vision". VisionWeb. 29 October 2001. Retrieved 2009-02-10.
- "FDA Updates Labeling for Viagra, Cialis and Levitra for Rare Post-Marketing Reports of Eye Problems". United States Food and Drug Administration. 8 July 2005. Archived from the original on February 23, 2008. Retrieved 2009-02-10.
- Pomeranz HD, Bhavsar AR (March 2005). "Nonarteritic ischemic optic neuropathy developing soon after use of sildenafil (viagra): a report of seven new cases". J Neuroophthalmol 25 (1): 9–13. doi:10.1097/00041327-200503000-00003. PMID 15756125.
- Egan R, Pomeranz H (February 2000). "Sildenafil (Viagra) associated anterior ischemic optic neuropathy". Arch. Ophthalmol. 118 (2): 291–2. PMID 10676804.
- Pomeranz HD, Smith KH, Hart WM, Egan RA (March 2002). "Sildenafil-associated nonarteritic anterior ischemic optic neuropathy". Ophthalmology 109 (3): 584–7. doi:10.1016/S0161-6420(01)00976-9. PMID 11874765.
- Cunningham AV, Smith KH (March 2001). "Anterior ischemic optic neuropathy associated with viagra". J Neuroophthalmol 21 (1): 22–5. doi:10.1097/00041327-200103000-00006.PMID 11315976.
- Boshier A, Pambakian N, Shakir SA (September 2002). "A case of nonarteritic ischemic optic neuropathy (NAION) in a male patient taking sildenafil". Int J Clin Pharmacol Ther 40 (9): 422–3. PMID 12358159.
- Akash R, Hrishikesh D, Amith P, Sabah S (August 2005). "Case report: association of combined nonarteritic anterior ischemic optic neuropathy (NAION) and obstruction of cilioretinal artery with overdose of Viagra". J Ocul Pharmacol Ther 21 (4): 315–7.doi:10.1089/jop.2005.21.315. PMID 16117695.
- "FDA Announces Revisions to Labels for Cialis, Levitra and Viagra". United States Food and Drug Administration. 18 October 2007. Archived from the original on 11 July 2007. Retrieved 10 February 2009.
- "Viagra (sildenafil citrate) tablets". page 29: Pzifer. October 2007. Retrieved 2009-10-25.
- Kloner RA (2005). "Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: focus on alpha-blocker interactions". Am J Cardiol 96 (12B): 42M–46M.doi:10.1016/j.amjcard.2005.07.011. PMID 16387566.
- Cheitlin MD, Hutter AM Jr, Brindis RG, Ganz P, Kaul S, Russell RO Jr, Zusman RM (1999). "ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association". Journal of the American College of Cardiology 33 (1): 273–82. doi:10.1016/S0735-1097(98)00656-1.PMID 9935041.
- Peterson K (2001-03-21). "Young men add Viagra to their drug arsenal". USAToday.
- Smith KM, Romanelli F (2005). "Recreational use and misuse of phosphodiesterase 5 inhibitors". J Am Pharm Assoc (2003) 45 (1): 63–72; quiz 73–5.doi:10.1331/1544345052843165. PMID 15730119.
- Sildenafil Will Not Affect Libido - Fact!
- Mondaini N, Ponchietti R, Muir GH, Montorsi F, Di Loro F, Lombardi G, Rizzo M (June 2003). "Sildenafil does not improve sexual function in men without erectile dysfunction but does reduce the postorgasmic refractory time". Int. J. Impot. Res. 15 (3): 225–8.doi:10.1038/sj.ijir.3901005. PMID 12904810.
- McCambridge J, Mitcheson L, Hunt N, Winstock A (March 2006). "The rise of Viagra among British illicit drug users: 5-year survey data". Drug Alcohol Rev 25 (2): 111–3.doi:10.1080/09595230500537167. PMID 16627299.
- Eloi-Stiven ML, Channaveeraiah N, Christos PJ, Finkel M, Reddy R (November 2007). "Does marijuana use play a role in the recreational use of sildenafil?". J Fam Pract 56 (11): E1–4.PMID 17976333.
- "The 2007 Ig Nobel Prize Winners". Improbable Research. 4 October 2007. Retrieved 2009-02-10.
- Agostino PV, Plano SA, Golombek DA (June 2007). "Sildenafil accelerates reentrainment of circadian rhythms after advancing light schedules". Proc. Natl. Acad. Sci. U.S.A. 104 (23): 9834–9. doi:10.1073/pnas.0703388104. PMC 1887561. PMID 17519328.
- Teri Thompson, Christian Red, Michael O'Keefffe, and Nathaniel Vinton (10 June 2008)."Source: Roger Clemens, host of athletes pop Viagra to help onfield performance". Daily News (Daily News). Retrieved 2009-02-10.
- Busbee J (2012-11-28). "Bears’ Brandon Marshall says some NFL players use Viagra … ON THE FIELD". Yahoo! Sports. Retrieved 2012-11-28.
- Siegel-Itzkovich J (July 1999). "In brief: Viagra makes flowers stand up straight". BMJ 319(7205): 274B. doi:10.1136/bmj.319.7205.274a. PMC 1126921. PMID 10426724.
- "Prolongation of the shelf life of fruits and flowers". Biology Department, University of Hamburg. Retrieved 28 November 2012.
- Oh SS, Zou P, Low MY, Koh HL. Detection of sildenafil analogues in herbal products for erectile dysfunction (2006). "Detection of sildenafil analogues in herbal products for erectile dysfunction". Journal of Toxicology and Environmental Health Part A 69 (21): 1951–1958.doi:10.1080/15287390600751355. PMID 16982533.
- Venhuis BJ, Blok-Tip L, de Kaste D (2008). "Designer drugs in herbal aphrodisiacs".Forensic Science International 177 (2–3): 25–27. doi:10.1016/j.forsciint.2007.11.007.PMID 18178354.
- FDA letter to Libidus distributor
- FDA Warns Consumers About Dangerous Ingredients in "Dietary Supplements" Promoted for Sexual Enhancement
- Hidden Risks of Erectile Dysfunction "Treatments" Sold Online
- R. Baselt, Disposition of Toxic Drugs and Chemicals in Man, 9th edition, Biomedical Publications, Seal Beach, CA, 2011, pp. 1552–1553.http://www.biomedicalpublications.com/dt9.pdf
- Sung, B. J.; Hwang, K.; Jeon, Y.; Lee, J. I.; Heo, Y. S.; Kim, J.; Moon, J.; Yoon, J.; Hyun, Y. L.; Kim, E.; Eum, S.; Park, S. Y.; Lee, J. O.; Lee, T.; Ro, S.; Cho, J. (2003). "Structure of the catalytic domain of human phosphodiesterase 5 with bound drug molecules". Nature 425 (6953): 98–102. doi:10.1038/nature01914. PMID 12955149.
- Webb, D.J.; Freestone, S.; Allen, M.J.; Muirhead, G.J. (March 4, 1999). "Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist". Am. J. Cardiol. 83 (5A): 21C–28C. doi:10.1016/S0002-9149(99)00044-2. PMID 10078539.
- "Viagra Clinical Pharmacology". RxList.com. 2008. Retrieved 2008-08-20.
- Dunn PJ (2005). "Synthesis of Commercial Phosphodiesterase(V) Inhibitors". Org Process Res Dev 2005 (1): 88–97. doi:10.1021/op040019c.
- "Research". ABM. Abertawe Bro Morgannwg University Health Board. 4 July 2008. Archived from the original on 26 September 2008. Retrieved 6 August 2008. "Our clinicians regularly offer patients the opportunity to take part in trials of new drugs and treatments. Morriston Hospital in Swansea, was the first in the world to trial Viagra!"
- Terrett NK, Bell AS, Brown D, Elllis P (1996). "Sildenafil (Viagra), a potent and selective inhibitor of Type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction". Bioorg Med Chem Lett 6 (15): 1819–1824. doi:10.1016/0960-894X(96)00323-X.
- Kling J (1998). "From hypertension to angina to Viagra". Mod. Drug Discov. 1: 31–38.ISSN 1532-4486. OCLC 41105083.
- Viagra sales peak at $1,934m in 2008
- Bellis M. "Viagra, the patenting of an aphrodisiac". About.com. Retrieved 2009-02-10.
- Ciment, J (1999). "Missouri fines internet pharmacy". BMJ (British Medical Journal) 319(7221): 1324. doi:10.1136/bmj.319.7221.1324g. PMC 1174637. PMID 10567131.
- Devine, Amy (September 29, 2008). "Chemists plan to sell Viagra on the internet". Daily Record. Retrieved 2012-04-30.
- "Urban Dictionary: Vitamin V". Urban Dictionary. January 16, 2009. Retrieved 2013-12-27.
- Keith A (2000). "The economics of Viagra". Health Aff (Millwood) 19 (2): 147–57.doi:10.1377/hlthaff.19.2.147. PMID 10718028.
- McGuire S (2007-01-01). "Cialis gaining market share worldwide". Medical Marketing & Media. Haymarket Media. Archived from the original on 2009-01-03. Retrieved 2009-02-10.
- Mullin, Rick (June 20, 2005). "Viagra". Chemical & Engineering News 83 (25). Retrieved 2008-08-20.
- Berenson, Alex (December 4, 2005). "Sales of Impotence Drugs Fall, Defying Expectations". The New York Times. Retrieved 2013-12-27.
- "Over-the-counter Viagra piloted". BBC News. BBC News. 11 February 2007. Retrieved 2009-02-10.
- "Pfizer to sell Viagra online, in first for Big Pharma: AP". CBS News. Retrieved 6 May 2013.
- "Actavis Launches Generic Viagra in Europe as Patents Expire". Retrieved 2013-10-25.
- Jim Edwards (October 21, 2009). "What Will Happen When Viagra Goes Generic?". AccessRx.com. Retrieved 2013-12-27.
- "Is Viagra about to lose its pulling power in the UK?". The Guardian. Retrieved 13 June 2013.
- Murray-, Rosie (23 January 2002). "Viagra ruling upsets Pfizer". London: Telegraph Media Group Limited. Archived from the original on 22 August 2009. Retrieved 10 February 2009.
- "Pfizer Loses UK Battle on Viagra Patent". UroToday. Thomson Reuters. 17 June 2002. Archived from the original on 25 June 2007. Retrieved 10 February 2009.
- U.S. Patent 5,250,534
- U.S. Patent 6,469,012
- "Pfizer Wins Viagra Patent Infringement Case Against Teva Pharmaceuticals". Bloomberg. August 15, 2011. Retrieved 2012-04-01.
- "Pfizer's Revatio Goes Generic". Zacks Equity Research. November 15, 2012. Retrieved 2013-10-05.
- "Revation patent ruled invalid for lack of sound prediction and obviousness". Canadian Technology & IP Law. Stikeman Elliott. 2010-06-18. Retrieved 2012-11-14.
- "Pfizer Canada Inc. v. Ratiopharm Inc., 2010 FC 612". CanLII.
- Teva Canada Ltd. v. Pfizer Canada Inc. 2012 SCC 60 at par. 80 (8 November 2012)
- John Spears (2012-11-08). "Supreme Court ruling could lead to cheaper versions of Viagra". The [Toronto] Star. Retrieved 2012-11-14.
- Ken Hanly (2012-11-08). "Canadian Supreme court rules Viagra patent invalid". Digital Journal. Retrieved 2012-11-14.
- "Viagra patent tossed out by Supreme Court: Decision allows generic versions of drug to be produced". CBC News. 2012-11-08. Retrieved 2012-11-14.
- "Pfizer Canada drops Viagra price after generic versions get Supreme Court green light".Financial Post. 2012-11-22. Retrieved 2013-12-27.
- "SCC Case Information, Docket No. 33951". Retrieved 2012-11-14.
- Kirk Makin (2012-11-15). "In rare move, Pfizer asks Supreme Court to reconsider ruling that killed Viagra patent". The Globe and Mail. Retrieved 2012-11-15.
- Gowling Lafleur Henderson LLP, Hélène D'Iorio (2013-04-22). "The Supreme Court of Canada holds Pfizer’s Viagra patent invalid". Lexology. Retrieved 2013-12-27.
- Allam, Abeer (October 4, 2002). "Seeking Investment, Egypt Tries Patent Laws". New York Times. Retrieved 2013-12-27.
- Viagra patent expires in June, says Brazilian court
Official Viagra Website
- Official Viagra UK Website
- Official Revatio Website
- prescribing information for Viagra and prescribing information for Revatio from Pfizer
- FDA Information
- MedlinePLUS information, including side effects
- U.S. National Library of Medicine: Drug Information Portal – Sildenafil
- Viagra bound to proteins in the PDB
- Viagra at The Periodic Table of Videos (University of Nottingham)